Cargando…
Measuring Fatigue in Multiple Sclerosis: There may be Trouble Ahead
INTRODUCTION: Poorly developed patient-reported outcome measures (PROs) risk type-II errors (i.e. false negatives) in clinical trials, resulting in erroneous failure to achieve trial endpoints. Validity is a fundamental requirement of fit-for-purpose PROs, with the main determinant of validity being...
Autores principales: | Close, James, Vandercappellen, Jo, King, Miriam, Hobart, Jeremy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444927/ https://www.ncbi.nlm.nih.gov/pubmed/37353721 http://dx.doi.org/10.1007/s40120-023-00501-9 |
Ejemplares similares
-
Symptom Interconnectivity in Multiple Sclerosis: A Narrative Review of Potential Underlying Biological Disease Processes
por: Chitnis, Tanuja, et al.
Publicado: (2022) -
Embodied Music Cognition: Trouble Ahead, Trouble Behind
por: Matyja, Jakub R.
Publicado: (2016) -
Mycobacterium abscessus subsp abscessus lung disease: ‘trouble ahead, trouble behind…’
por: Griffith, David E.
Publicado: (2014) -
Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?
por: Bharadia, Trishna, et al.
Publicado: (2022) -
Measles outbreak: a warning sign of troubles ahead
por: Kaić, Bernard, et al.
Publicado: (2019)